MarketScreener Editorial Features Prime Medicine, Inc.
Equities
PRME
US74168J1016
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.790 USD | +2.43% |
|
+7.06% | +9.22% |
| 19/03 | Prime Medicine, Inc. Presents at The Citizens Life Sciences Conference 2026, Mar-11-2026 02:15 PM | |
| 12/03 | Oppenheimer Initiates Prime Medicine at Outperform With $11 Price Target | MT |
MarketScreener Editorial Features
Search
No results for this search
- Stock Market
- Equities
- PRME Stock
- News Prime Medicine, Inc.
- MarketScreener Editorial Features
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition